Synthesis characterization and cytotoxicity studies of platinum(II) complexes with reduced amino pyridine schiff base and its derivatives as ligands

References

• Gómez-Ruiz S, Maksimović-Ivanić D, Mijatović S, et al. On the discovery, biological effects, and use of cisplatin and metallocenes in anticancer chemotherapy [J]. Bioinorg Chem Appl. 2012;2012:24–30.
   Web of Science ®Google Scholar
• Yao X, Panichpisal K, Kurtzman N, et al. Cisplatin nephrotoxicity: a review. Am J Med Sci. 2007;334:115–124.10.1097/MAJ.0b013e31812dfe1e
   PubMed Web of Science ®Google Scholar
• Pasqua AJD, Goodisman J, Dabrowiak JC. Understanding how the platinum anticancer drug carboplatin works: from the bottle to the cell. Inorg Chim Acta. 2012;389:29–35.10.1016/j.ica.2012.01.028
   Web of Science ®Google Scholar
• Natile G, Marzilli LG. Non-covalent interactions in adducts of platinum drugs with nucleobases in nucleotides and DNA as revealed by using chiral substrates. Coord Chem Rev. 2006;250:1315–1331.10.1016/j.ccr.2005.12.004
   Web of Science ®Google Scholar
• Carlone M, Marzilli LG, Natile G. Platinum complexes with NH groups on the carrier ligand and with only one guanine or hypoxanthine derivative. Informative models for assessing relative nucleobase and nucleotide hydrogen-bond interactions with amine ligands in solution. Inorg Chem. 2004;43:584–592.10.1021/ic030236e
   PubMed Web of Science ®Google Scholar
• Boulikas T. Molecular mechanisms of cisplatin and its liposomally encapsulated form, Lipoplatin™. Lipoplatin™ as a chemotherapy and antiangiogenesis drug. Cancer Ther. 2007;5:351–376.
   Google Scholar
• Acharya S, Kejriwal A, Biswas AN, et al. Synthesis, characterization, X-ray structure and spectroscopic study of platinum(II) complexes with tridentate diazene ligands having O, N, S donor set. Inorg Chim Acta. 2013;394:757–764.10.1016/j.ica.2012.09.041
   Web of Science ®Google Scholar
• Andrepont C, Marzilli PA, Pakhomova S, et al. Guanine nucleobase adducts formed by a monofunctional complex: [Pt(N-(6-methyl-2-picolyl)-N-(2-picolyl)amine)Cl]Cl. J Inorg Biochem. 2015;153:219–230.10.1016/j.jinorgbio.2015.06.023
   PubMed Web of Science ®Google Scholar
• Hambley TW. The influence of structure on the activity and toxicity of Pt anti-cancer drugs. ChemInform. 1998;166:181–223.
   Google Scholar
• Reedijk J. Improved understanding in platinum antitumour chemistry. Chem Commun. 1996;7:801–806.10.1039/cc9960000801
   Web of Science ®Google Scholar
• Jamieson ER, Lippard SJ. Structure, recognition, and processing of cisplatin−DNA adducts. Chem Rev. 1999;99:2467–2498.10.1021/cr980421n
   PubMed Web of Science ®Google Scholar
• Lippert B. Structure and dynamics of Pt anticancer 50 drug adducts from nucleotides to oligonucleotides as revealed by NMR methods [M]. Cisplatin: Chem Biochem Leading Anticancer Drug Verlag Helv Chim Acta. 2006;10:247–291.
   Google Scholar
• Marzilli LG, Saad JS, Kuklenyik Z, et al. Relationship of solution and protein-bound structures of DNA duplexes with the major intrastrand cross-link lesions formed on cisplatin binding to DNA. J Am Chem Soc. 2001;123:2764–2770.10.1021/ja0007915
   PubMed Web of Science ®Google Scholar
• Motswainyana WM, Onani MO, Madiehe AM, et al. Imino-quinolyl palladium(II) and platinum(II) complexes: synthesis, characterization, molecular structures and cytotoxic effect. Inorg Chim Acta. 2013;400:197–202.10.1016/j.ica.2013.02.029
   Web of Science ®Google Scholar
• Matesanz AI, Leitao I, Souza P. Palladium(II) and platinum(II) bis(thiosemicarbazone) complexes of the 2,6-diacetylpyridine series with high cytotoxic activity in cisplatin resistant A2780cisR tumor cells and reduced toxicity. J Inorg Biochem. 2013;125:26–31.10.1016/j.jinorgbio.2013.04.005
   PubMed Web of Science ®Google Scholar
• Aslam M, Anis I, Afza N, et al. Antibacterial and lipoxygenase (LOX) inhibitory activities of 2-[(2- methoxybenzylidene)amino]phenol derivatives. 2013;4:26–31.
   Google Scholar
• Aslan HG, Özcan S, Karacan N. Synthesis, characterization and antimicrobial activity of salicylaldehyde benzenesulfonylhydrazone (Hsalbsmh) and its nickel(II), palladium(II), platinum(II), copper(II), cobalt(II) complexes. Inorg Chem Commun. 2011;14:1550–1553.10.1016/j.inoche.2011.05.024
   Web of Science ®Google Scholar
• Al-Allaf TAK, Sheet AZM. Platinum group metal Schiff base complexes—I. Platinum complexes. Polyhedron. 1995;14:239–248.10.1016/0277-5387(94)00231-3
   Web of Science ®Google Scholar
• Cuny GD, Landgrebe KD, Smith TP, et al. Photoactivated virucidal properties of tridentate 2,2′-dihydroxyazobenzene and 2-salicylideneaminophenol platinum pyridine complexes. Bioorg Med Chem Lett. 1999;9:237–240.10.1016/S0960-894X(98)00714-8
   PubMed Web of Science ®Google Scholar
• Sharma K, Singh RV, Fahmi N. Palladium(II) and platinum(II) derivatives of benzothiazoline ligands: synthesis, characterization, antimicrobial and antispermatogenic activity. Spectrochim Acta Part A Mol Biomol Spectrosc. 2011;78:80–87.10.1016/j.saa.2010.08.076
   PubMed Web of Science ®Google Scholar
• Shimazaki Y, Arai N, Dunn TJ, et al. Influence of the chelate effect on the electronic structure of one-electron oxidized group 10 metal(II)-(disalicylidene)diamine complexes. Dalton Trans. 2011;40:2469–2479.10.1039/c0dt01574a
   PubMed Web of Science ®Google Scholar
• Proetto M, Liu W, Hagenbach A, et al. Synthesis, characterization and in vitro antitumour activity of a series of novel platinum(II) complexes bearing Schiff base ligands. Eur J Med Chem. 2012;53:168–175.10.1016/j.ejmech.2012.03.053
   PubMed Web of Science ®Google Scholar
• Ma XF, Li DD, Tian JL, et al. DNA binding and cleavage activity of reduced amino-acid Schiff base complexes of cobalt(II), copper(II), and cadmium(II). Transition Metal Chem. 2009;34:475–481.10.1007/s11243-009-9219-7
   Web of Science ®Google Scholar
• Gao EJ, Liang SK, Ma C, et al. A novel Mn(II) complex with 3-(2,5-dicarboxyl)-5-carboxylpyridine: synthesis, crystal structure, and interaction with DNA. Russian J Coord Chem. 2015;41:599–606.10.1134/S107032841509002X
   Web of Science ®Google Scholar
• Katarzyna K, Katarzyna S, Agnieszka M, et al. Synthesis, structure and antiarrhythmic properties evaluation of new basic derivatives of 5,5-diphenylhydantoin. Eur J Med Chem. 2003;34:555–566.
   Google Scholar
• Das T, Ghosh D, Bhattacharyya TK, et al. Biocompatibility of diamond-like nanocomposite thin films. J Mater Sci Mater Med. 2007;18:493–500.10.1007/s10856-007-2009-x
   PubMed Web of Science ®Google Scholar
• Nakabayashi Y, Erxleben A, Létinois U, et al. Spontaneous reduction of mixed 2,2′-bipyridine/methylamine/chloro complexes of Pt(IV) in water in the presence of light is accompanied by complex isomerization, loss of methylamine, and formation of a strong oxidant, presumably HOCl. Chem – A Eur J. 2007;13:3980–3988.10.1002/(ISSN)1521-3765
   PubMed Web of Science ®Google Scholar
• (a) Guo SX, Mason DN, Turland SA, et al. Systematic differences in electrochemical reduction of the structurally characterized anti-cancer platinum(IV) complexes [Pt{((p –HC6 F4)NCH2) 2 -(pyridine)2 Cl2 ], [Pt{((p –HC6 F4)NCH2) 2 (pyridine)2 (OH)2 ], and [Pt{((p -HC6 F4)NCH. J Inorg Biochem. 2012;115:226–239; (b) Zhang JZ, Wexselblatt E, Hambley TW, et al. Pt(IV) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbate. Chem Commun. 2011;48:847–849.10.1016/j.jinorgbio.2012.07.016
   PubMed Web of Science ®Google Scholar
• Nawar N, Hosny NM. Synthesis, spectral and antimicrobial activity studies of o-aminoacetophenone o-hydroxybenzoylhydrazone complexes. Transition Metal Chem. 2000;25:1–8.10.1023/A:1007080122211
   Web of Science ®Google Scholar
• Skladanowski A, Bozko P, Sabisz M. ChemInform abstract: DNA structure and integrity checkpoints during the cell cycle and their role in drug targeting and sensitivity of tumor cells to anticancer treatment. Cheminform. 2009;109:2951–2973.
   Google Scholar
• Dong ZC, Zhang XL, Gao HY, et al. Generation of molecular hot electroluminescence by resonant nanocavity plasmons [J]. Nat Photonics. 2010;4:50–54.10.1038/nphoton.2009.257
   Web of Science ®Google Scholar
• Liangnian JI, Zhang QL, Liu J. DNA structure, binding mechanism and biology functions of polypyridyl complexes in biomedicine. Sci China. 2001;44:246–259.
   Google Scholar
• Cao PR, Mchugh MM, Melendy T, et al. The DNA minor groove-alkylating cyclopropylpyrroloindole drugs adozelesin and bizelesin induce different DNA damage response pathways in human colon carcinoma HCT116 cells. Mol Cancer Ther. 2003;2:651–659.
   PubMed Web of Science ®Google Scholar
• Zhao J, Gou S, Sun Y, et al. Antitumor platinum(II) complexes containing platinum-based moieties of present platinum drugs and furoxan groups as nitric oxide donors: synthesis, DNA interaction, and cytotoxicity. Inorg Chem. 2012;51:10317–10324.10.1021/ic301374z
   PubMed Web of Science ®Google Scholar
• Xie L, Cui J, Qian X, et al. 5-non-amino aromatic substituted naphthalimides as potential antitumor agents: synthesis via suzuki reaction, antiproliferative activity, and DNA-binding behavior. Bioorg Med Chem. 2011;19:961–967.10.1016/j.bmc.2010.11.055
   PubMed Web of Science ®Google Scholar